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INTRODUCTION
For the last 15 years, intravenous thrombolysis (TL) has
been the only active treatment method for acute ischemic
stroke within the first 4.5 hours from the onset of symptoms
(Wahlgren et al., 2007; Hacke et al., 2008; Khatri et al.,
2009). Recent studies have shown that results of thromboly-
sis might be suboptimal in patients with large artery occlu-
sion and if the length of thrombus exceeds 8 mm (Tomsick
et al., 2008; Riedel et al., 2011). Several studies in 2013
presented mechanical thrombectomy (TE) as a new ap-
proach to ischemic stroke patients; the majority of these
cases showed that thrombectomy did not have better out-
come than thrombolysis (Broderic et al., 2013; Ciccone et
al., 2013; Kidwell et al., 2013). The studies were criticised
for the lack of multimodal computed tomography (CT) ex-
amination protocols, the use of different thrombectomy de-
vices and small patient groups. Several new studies pub-
lished in 2015 showed superiority of thrombectomy over
thrombolysis because of better patient selection for this
treatment method (Berkhemer et al., 2015; Compbell et al.,
2015; Goyal et al., 2015). Thrombectomy as a treatment
method for acute ischemic stroke was established in 2010 in
Latvia. There have been few small previous studies charac-
terising mechanical endovascular therapy, but there are no
previous studies analysing and comparing both treatment
methods in Latvia (Balodis et al., 2015).
The aim of this study was to evaluate the results of endovas-
cular treatment in patients with proximal vessel occlusion,
compare results of this group with those from an intrave-
nous thrombolysis group and to identify possible criteria of
active treatment.
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Mechanical thrombectomy as an active treatment method has recently been chosen for patients
with large artery occlusions and thrombolysis beyond a time window. The aim of our study was to
evaluate the results of endovascular treatment in patients with proximal vessel occlusion, com-
pare this group with the intravenous thrombolysis group, and to identify possible criteria of active
treatment. The prospective study included 81 patients hospitalised in the Pauls Stradiòð Clinical
University Hospital due to acute ischemic stroke; 48 of them received mechanical thrombectomy
and 33 — intravenous thrombolysis. Thrombectomy (TE) was performed using Solitaire FR stent
retrievers. The NIHSS score was used for evaluation of early therapy results and mRS (modified
Rankin Scale) was used for late therapy results. ASPECTS was used to define the lesion size us-
ing imaging on admission and after treatment. Median NIHSS on admission was higher in the TE
group — 16 (range 12 to 19) than in the TL group — 12 (range 8 to 15) (p < 0.05). Ninety days af-
ter treatment, mRS (0–2) was seen in 67% of patients in the TE group (n = 29), and 34% of pa-
tients in the TL group (n = 9) patients (p < 0.05). Median ASPECTS was lower in TE group — 5,
in comparison to the TL group — 7 (p < 0.01) Mortality frequency was higher in the TL group (p >
0.05). Frequency of symptomatic intracerebral haemorrhages was similar in the groups. Mechani-
cal thrombectomy can achieve better late functional outcome than thrombolysis in a selected pa-
tients group.
Key words: ischemic stroke, thrombectomy, thrombolysis, criteria of active treatment.
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MATERIALS AND METHODS
A prospective, cross-sectional cohort study was conducted
on 81 patients with acute ischemic stroke, who were hospi-
talised in the Pauls Stradiòð Clinical University Hospital
(PSKUS), in the period from January 2013 till December
2014. The study was approved by the Ethics Committee of
Rîga Stradiòð University. Patients were divided into two
groups. The first group included patients who received
thrombectomy with or without intravenous thrombolysis
(TE group) and the second consisted of patients who re-
ceived only intravenous thrombolysis (TL group). The TE
group consisted of 48 patients, 32 patients received only
thrombectomy, and 16 patients received combined therapy
— thrombectomy with thrombolysis. Thrombectomy was
performed within 8 hours from onset of symptoms. All the
thrombectomies were performed using stent retrievers Soli-
taire FR. The TL group consisted of 33 patients who re-
ceived thrombolysis with intravenous t-PA within 4.5 hours
from symptom onset.
Multimodal computed tomography, including non-contrast
CT, CT angiography (CTA) and CT perfusion (CTP), was
performed for all patients. The area detectable on CTP sur-
rounding necrosis is the potentially viable hypoperfused
brain tissue, called penumbra. Additionally, digital subtrac-
tion angiography (DSA) was performed for patients who re-
ceived combined therapy. Successful revascularisation was
evaluated with the use of the Thrombolysis in Cerebral In-
farction (TICI) scale. The scale ranges from 0 (no perfu-
sion) to 3 (full perfusion). Complete revascularisation was
evaluated as a TICI score of 2b to 3.
To evaluate the neurological status on admission, the Na-
tional Institutes of Health Stroke Scale (NIHSS) was used.
Lesion size at admission was estimated from computed to-
mography imaging using the Alberta Stroke Programme
Early CT score (ASPECTS). A more detailed explanation
of ASPECTS is shown in Figure 1.
Early results of applied therapy were evaluated also using
ASPECTS and NIHSS at 24 hours after the treatment. Late
therapy results were evaluated using the modified Rankin
Scale (mRS) at discharge from hospital and 90 days after
therapy. Collaterals were analysed using validated classifi-
cation and were divided into two groups: good and poor
(Tan et al., 2009).
Patients who died during hospitalisation were not included
in this study because they did not meet the inclusion crite-
ria; the majority of them had malignant collaterals, large
core (necrosis) area and had an ASPECTS score less than 5.
Inclusion and exclusion criteria are shown in Table 1.
Mortality was analysed at 90 days after therapy.
Data were analysed using Microsoft Excel and SPSS 20.
Linear data were tested for normality using Shapiro–Wil-
coxon and Kolmogorov–Smirnov tests, if the p value was
less than 0.05, the data were not considered to be normally
distributed. Median and interquartile range was used for lin-
ear data characteristics. The Mann–Whitney test was used
to compare median data in thrombectomy and thrombolysis
groups. Spearman’s correlation analysis was used to evalu-
ate relationships between two linear data groups. The Chi-
Square test was used for conclusive statistics. A p value less
than 0.05 was considered as statistically significant.
RESULTS
Neurological status was evaluated within both groups using
NIHSS on admission. Median NIHSS on admission was
significantly higher (p < 0.05) in the TE group — 16 (range
12 to 19) than in the TL group — 12 (range 8 to 15).
Early treatment results were evaluated using NIHSS: me-
dian NIHSS after the treatment was significantly lower (p <
0.01) in the TE group — 4 (range 2 to 7), compared to 7
(range 2 to 16) in the TL group.
Fig. 1. ASPECTS score. A: The level at the basal ganglia, C, caudate nu-
cleus, I, insula, IC, internal capsule, L, lentiform nucleus, M1, anterior cor-
tex of MCA, M2, lateral cortex of MCA, M3, posterior cortex of MCA. B:
Supraganglionic level. M4, anterior cortex of MCA, M5, lateral cortex of
MCA, M6, posterior cortex of MCA. 10 point system: normal = 10 points,
each lesion – 1 point.
T a b l e 1
INCLUSION AND EXCLUSION CRITERIA OF THE PATIENTS




- ASPECTS score  5
- Good, poor collaterals
- CT native, CT
angiography, CT
perfusion
- Time window TE
group till 8 hours, TL
group 4.5 hours
- ACI proximal and
distal, ACM M1, M2
segment occlusion
- ASPECTS score < 5
- Malignant collaterals
- Not performed CT
angiography or CT
perfusion
- Time window TE
group > 8 hours, TL
group > 4.5 hours
- ACM M3, M4 segment
oclussion
ACI, Arteria carotis interna; ACM, Arteria cerebris media; M1, middle ce-
rebral artery from the origin to bifurcation; M2, middle cerebral artery
from bifurcation to origin of cortical branches; M3, middle cerebral artery
opercular branches; M4, middle cerebral artery branches emerging from
the Sylvian fissure to the convex surface of the hemisphere.
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Median NIHSS after therapy was significantly lower (p <
0.05) in the TL group among patients with good collaterals
— 4, compared to 15 in patients with poor collaterals; there
was no significant difference in the TE group (p > 0.05).
Mortality at 90 days was 11% in the TE group (n = 4) and
29% in the TL group (n = 8), with no significant difference
between groups (p > 0.05). The number of complications
(intracerebral haemorrhage) was equal in both groups (TE 9
patients, TL 9 patients). Baseline and neurological status
characteristics are shown in Table 2.
Median ASPECTS values were significantly lower (p <
0.01) in the TE group — 5 (range 4–6), corresponding to
larger size stroke than in the TL group — 7 (range 5–8).
There was a negative significant Spearman’s correlation be-
tween the ASPECTS score at 24 hours follow-up and com-
puted tomography NIHSS score at discharge negative,
showing higher NIHSS values in larger size stroke (lower
ASPECTS score), (rs = –0.63, p < 0.01) in TE group and
(rs = –0.44, p < 0.05) in TL group. Radiological investiga-
tion characteristics are shown in Table 3.
Patients were also analysed by occlusion site. More proxi-
mal occlusions (Arteria carotis interna, ACI) had higher
median NIHSS score values and higher median mRS values
among therapy groups (TE vs TL (NIHSS 4 vs. 10, mRS 3
vs. 5) at discharge. There was a significant functional im-
provement (mRS improvement by 1–2 values) in both treat-
ment groups, particularly for the TE group in intracranial
ACM (Arteria cerebris media) proximal and ACI occlu-
sions (p = 0.05), shown in Table 4.
Patients with a mRS score of 0, 1 or 2 are rated as function-
ally independent. There was a significant difference be-
tween treatment groups (p < 0.05) in patients with func-
tional independence at 90 days (mRS 0–2) — in the TE
T a b l e 2
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NIHSS score admission
Median 16 12
Interquartile range 12–19 8–15
NIHSS score after therapy
Median 4 7
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group 67% (n = 29) and in the TL group 34% (n = 9). Dis-
tribution of the mRS scores 90 days after treatment within
TE and TL groups are shown in Figure 2.
DISCUSSION
Thrombectomy as a new treatment method was criticised in
several trials published in 2013 which showed that there is
no better functional outcome comparing thrombectomy with
thrombolysis (Broderic et al. 2013), as the modified Rankin
score of 2 or less at 90 days did not significantly difference
between groups — 40.8% with endovascular therapy and
38.7% with intravenous t-PA. Thrombectomy is a new
treatment method that has been performed relatively rarely
in early multicenter trials without the necessary multimodal
vascular imaging technologies prior to endovascular inter-
vention, which may affect results. Our study showed sig-
nificant difference between treatment groups (thrombec-
tomy 67% vs. thrombolysis 34%) in favour of endovascular
and combined therapy, which can be a result of the more re-
cent stent retriever system use and adequate pretreatment
imaging. Our data correspond to similar results published
by Campbell et al. (2015), where the TE group had a higher
rate of functional independence after 90 days (mRS 0–2) —
thrombectomy 71% vs. thrombolysis 40%.
Thrombectomy as a treatment method can be effective in
situations when thrombolysis cannot be performed because
of time limitations or contraindications.
Our study showed that patients who received thrombectomy
were hospitalised with significantly higher median NIHSS
than in the TL group (TE – 10 patients vs. TL – 4 patients).
This may be explained by the higher proportion of ACI oc-
clusion in the TE group, which leads to larger lesion size
and more severe neurological impairment. Thrombectomy
was also performed for those patients who did not receive
thrombolysis because of a limited time window.
Successful recanalisation was performed in 91% of our TE
patients, while other trials show lower recanalisation rates
(65–81%, depending on occlusion site) (Broderick et al.,
2013), which can be explained by procedure technical rea-
sons. All of our patients received thrombectomy by using
stent retrievers Solitaire FR, while other previous trials used
first generation thrombectomy devices, such as a Merci Re-
triever (Kidwell et al., 2013).
Several studies have showed that good collaterals have an
impact on treatment outcomes (Shi et al., 2010). Our study
showed that good collaterals are more important within the
TL group, but without significant impact on thrombectomy
results. This can be explained by the fact that patients with
malignant collaterals were excluded from this study and re-
canalisation was achieved in patients with good and poor
collaterals.
This study also showed that carefully selected patients for
TE can achieve a better outcome, however, both treatment
methods were equally safe and combined therapy did not
show a significant raise of haemorrhagic complications. In-
tracerebral haemorrhages were detected in both groups, as
observed in the MR CLEAN study (Berkhemer et al.,
2015). Higher mortality 90 days after treatment was de-
tected in the TL group — 29% (11% in the TE group),
which can be explained by poorer recanalisation rate in pa-
tients with ACI occlusions and TL (results showed in Table
4). Similar results with higher mortality in a TL group —
19% than in a TE group — 10% were published by (Goyal
et al., 2015).
There were some limitations of our study. Our study groups
were small, and the TE group had more patients. Another
limitation was that the TE group consisted of patients who
received only thrombectomy and patients who received
combined therapy with thrombolysis, which might have af-
fected the results. Unequal distribution of patients — the
majority of patients included in TE group had proximal ACI
occlusion — affected the median NIHSS on admission.
In conclusion, our study results show that mechanical
thrombectomy can achieve better late clinical outcome than
thrombolysis in a selected patient group. Treatment results
as well as the clinical outcome are related to the use of the
latest stent retriever systems. Our results show that the pre-
treatment multimodal computed tomography examination is
vital for patient selection for active treatment.
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AKÛTA CEREBRÂLA INFARKTA ENDOVASKULÂRA ÂRSTÇÐANA PACIENTIEM AR MAÌISTRÂLO ARTÇRIJU OKLÛZIJÂM
Trombektomija kâ aktîvas ârstçðanas metode akûta cerebrâla infarkta gadîjumâ arvien bieþâk tiek lietota pacientiem ar maìistrâlo asinsvadu
oklûzijâm. Pçtîjuma mçríis bija novçrtçt trombektomijas rezultativitâti pacientiem ar maìistrâlo asinsvadu oklûzijâm priekðçjâ smadzeòu
cirkulâcijâ, salîdzinât rezultâtus ar trombolîzes grupu, kâ arî atklât iespçjamos papildus kritçrijus aktîvas terapijas pielietoðanai. Pçtîjumâ
tika iekïauts 81 pacients ar akûtu cerebrâlu infarktu, kuri tikuði stacionçti Paula Stradiòa Klîniskajâ universitâtes slimnîcâ, 48 no pacientiem
tika veikta trombektomija, 33 — trombolîze. Trombektomijas tika veiktas, izmantojot Solitaire FR ierîci. Neiroloìiskâ statusa novçrtçðanai
sâkotnçji un agrîno rezultâtu novçrtçðanai tika izmantota NIHSS skala, mRS skala tika lietota vçlîno neiroloìisko rezultâtu novçrtçðanai,
izrakstoties un pçc 90 dienâm. ASPECTS skala tika lietota smadzeòu bojâjuma apjoma novçrtçðanai ar attçldiagnostiku, iestâjoties un pçc
terapijas. Mediânâ NIHSS vçrtîba iestâjoties bija augstâka pacientiem trombektomijas grupâ — 16 (izkliede no 12 lîdz 19), trombolîzes
grupâ — 12 (izkliede no 8 lîdz 15) (p < 0,05). Trombektomijas grupâ 90 dienas pçc terapijas pacienti ar maznozîmîgu neiroloìisku defektu
— mRS (0–2) sastâdîja 67% (n = 29), savukart trombolîþu grupâ tikai 34% (n = 9) (p < 0,05). Mediânâs ASPECTS vçrtîbas bija zemâkas
trombektomiju grupâ — 5 (izkliede no 4 lîdz 6), trombolîþu — 7 (izkliede no 5 lîdz 8) (p < 0,01). Mirstîba bija augstâka trombolîþu grupâ
(p > 0,05). Mûsu pçtîjuma rezultâti liecina, ka ar mehânisku trombektomiju var sasniegt labâku vçlîno klînisko iznâkumu, nekâ lietojot
intravenozu trombolîzi pacientiem ar maìistrâlo asinsvadu oklûziju. Ârstçðanas rezultâti, kâ arî klîniskais iznâkums ir saistîts ar jaunâkâs
paaudzes trombektomijas ierîces izmantoðanu. Agrînai multimodâlai datortomogrâfijas izmeklçðanai ir ïoti svarîgi, lai pacienti tiktu atlasîti
aktîvai ârstçðanai.
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